Searched for
KRISHNAKUMAR VAIDYANATHAN
Eris Lifesciences reports 41% year-on-year rise in net profit in Q1Eris Lifesciences reported a robust 41% YoY increase in net profit, reaching Rs 125 crore for the first quarter, driven by strong performan...- Eris Lifesciences eyes ‘good’ share in semaglutide generics, says COOEris Lifesciences plans to lead in generic semaglutide drugs. The patent for Novo Nordisk's drug expires in India in March 2026. Eris aims ...
- Buy Eris Lifesciences, target price Rs 710: Motilal Oswal Financial ServicesEris Lifesciences, incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 7871.82 Crore) operating in Pharmaceutica...
- Buy Eris Lifesciences, target price Rs 780: Motilal Oswal Financial ServicesEris Lifesciences, incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 8701.37 Crore) operating in Pharmaceutica...
- Bench reserves verdict on appeals challenging single judge order against AIADMK's Jul 11 GC meetEPS had preferred the appeal against Justice Jayachandran's order declaring as invalid the July 11 GC meet and the decisions therein, besid...
Load More